Observational studyJournal of cancer research and clinical oncology2025
Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab-bendamustine in follicular lymphoma: a single-center case series study.
Matteo D'Addona et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.